Uniqure NV (QURE): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 62,349 US Dollar | 9 | 1 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 69.366.412 | 12,73 | 2,9 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Uniqure NV
Mitarbeiter 221
Handelsplatz NASDAQ
Ticker Symbol QURE
IPO Datum 2007-06-20
Adresse Paasheuvelweg 25, Amsterdam, Netherlands, 1105 BP
Webseite https://www.uniqure.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Matthew Craig Kapusta CPA | CEO & Executive Director |
| 2 | Mr. Christian Klemt | CFO, Principal Financial Officer & GM of Amsterdam Site |
| 3 | Dr. Jeannette Potts J.D., Ph.D. | Chief Legal & Compliance Officer and Corporate Secretary |
| 4 | Dr. Walid Abi-Saab M.D. | Chief Medical Officer |
| 5 | Prof. Hugo Katus | Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany |
| 6 | Dr. Amin Abujoub Ph.D. | Chief Technical Operations Officer |
| 7 | Mr. Richard Porter Ph.D. | Chief Business & Scientific Officer |
| 8 | Ms. Chiara Elizabeth Russo | Senior Director of Investor Relations |
| 9 | Dr. Tamara Tugal Ph.D., MBA | Business Development Director |
| 10 | Ms. Erin Boyer | Chief People & Culture Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | venBio Select Advisor LLC | 9,70% | 0,15 Mrd. USD |
| 2 | JPMorgan Chase & Co | 7,02% | 0,11 Mrd. USD |
| 3 | RTW INVESTMENTS, LLC | 5,68% | 0,09 Mrd. USD |
| 4 | State Street Corp | 4,19% | 0,07 Mrd. USD |
| 5 | Aberdeen Group PLC | 4,11% | 0,06 Mrd. USD |
| 6 | BlackRock Inc | 2,71% | 0,04 Mrd. USD |
| 7 | Orbimed Advisors LLC | 2,61% | 0,04 Mrd. USD |
| 8 | Jane Street Group LLC | 2,32% | 0,04 Mrd. USD |
| 9 | Jennison Associates LLC | 2,25% | 0,04 Mrd. USD |
| 10 | Boxer Capital Management, LLC | 2,17% | 0,03 Mrd. USD |
| 11 | The Goldman Sachs Group Inc | 2,13% | 0,03 Mrd. USD |
| 12 | Two Sigma Investments LLC | 2,11% | 0,03 Mrd. USD |
| 13 | Two Seas Capital LP | 1,87% | 0,03 Mrd. USD |
| 14 | FMR Inc | 1,83% | 0,03 Mrd. USD |
| 15 | Mak Capital One LLC | 1,78% | 0,03 Mrd. USD |
| 16 | MPM Oncology Impact Management LP | 1,77% | 0,03 Mrd. USD |
| 17 | Morgan Stanley - Brokerage Accounts | 1,54% | 0,02 Mrd. USD |
| 18 | Assenagon Asset Management SA | 1,48% | 0,02 Mrd. USD |
| 19 | Vestal Point Capital LP | 1,35% | 0,02 Mrd. USD |
| 20 | Maverick Capital Ltd | 1,33% | 0,02 Mrd. USD |